End-of-day quote
Korea S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
132,300
KRW
|
+0.15%
|
|
+0.99%
|
+32.96%
|
Apr. 26 |
ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd
|
CI
| Apr. 25 |
ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd
|
CI
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,978,987
|
3,361,880
|
2,751,988
|
2,322,178
|
2,750,675
|
3,565,437
|
-
|
-
|
Enterprise Value (EV)
1 |
1,978,987
|
3,361,880
|
2,751,988
|
2,322,178
|
2,750,675
|
3,565,437
|
3,565,437
|
3,565,437
|
P/E ratio
|
6.52
x
|
4.63
x
|
3.75
x
|
5.1
x
|
6.68
x
|
4.9
x
|
4.47
x
|
4.06
x
|
Yield
|
2.52%
|
2.37%
|
4.67%
|
-
|
-
|
3.42%
|
3.76%
|
4.58%
|
Capitalization / Revenue
|
2.29
x
|
2.29
x
|
1.5
x
|
1.83
x
|
2.37
x
|
2.26
x
|
2.15
x
|
1.93
x
|
EV / Revenue
|
2.29
x
|
2.29
x
|
1.5
x
|
1.83
x
|
2.37
x
|
2.26
x
|
2.15
x
|
1.93
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
0.79
x
|
0.96
x
|
0.65
x
|
-
|
-
|
0.64
x
|
0.57
x
|
0.51
x
|
Nbr of stocks (in thousands)
|
24,893
|
26,576
|
25,720
|
27,645
|
27,645
|
26,950
|
-
|
-
|
Reference price
2 |
79,500
|
126,500
|
107,000
|
84,000
|
99,500
|
132,300
|
132,300
|
132,300
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/11/22
|
2/10/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
865.1
|
1,469
|
1,835
|
1,269
|
1,160
|
1,577
|
1,659
|
1,844
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
473.7
|
954.9
|
1,209
|
656.4
|
564.7
|
987.1
|
1,053
|
1,142
|
Operating Margin
|
54.76%
|
65%
|
65.87%
|
51.74%
|
48.69%
|
62.58%
|
63.48%
|
61.92%
|
Earnings before Tax (EBT)
1 |
492.2
|
970.2
|
1,234
|
680.2
|
585.1
|
993.8
|
1,064
|
1,142
|
Net income
1 |
362.8
|
693.9
|
903.7
|
508.2
|
440.7
|
729.1
|
792.3
|
847
|
Net margin
|
41.94%
|
47.23%
|
49.24%
|
40.05%
|
38.01%
|
46.22%
|
47.75%
|
45.93%
|
EPS
2 |
12,193
|
27,314
|
28,546
|
16,478
|
14,889
|
26,999
|
29,567
|
32,592
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
2,000
|
3,000
|
5,000
|
-
|
-
|
4,523
|
4,973
|
6,060
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/11/22
|
2/10/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
468.4
|
421.2
|
355.3
|
289
|
328.9
|
295.5
|
540.3
|
334
|
342.6
|
-132.6
|
419.2
|
385.8
|
374.8
|
366.3
|
414
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
320.9
|
248.1
|
213.2
|
127.2
|
179.2
|
136.7
|
388.9
|
180.9
|
271.9
|
-277
|
266.4
|
224.6
|
227.1
|
232.2
|
258
|
Operating Margin
|
68.52%
|
58.91%
|
60.01%
|
44.04%
|
54.49%
|
46.27%
|
71.98%
|
54.16%
|
79.35%
|
208.85%
|
63.55%
|
58.21%
|
60.59%
|
63.38%
|
62.32%
|
Earnings before Tax (EBT)
1 |
323.3
|
241.3
|
214.8
|
128.4
|
190.7
|
146.2
|
395.8
|
176
|
261.5
|
-248.3
|
284.5
|
237
|
240.6
|
267
|
266
|
Net income
1 |
232.7
|
188.1
|
140.9
|
108.5
|
123.5
|
135.3
|
291.5
|
133.3
|
202.8
|
-191.4
|
199.6
|
172.2
|
172.7
|
183.8
|
204
|
Net margin
|
49.67%
|
44.67%
|
39.67%
|
37.54%
|
37.54%
|
45.78%
|
53.96%
|
39.92%
|
59.2%
|
144.32%
|
47.61%
|
44.64%
|
46.08%
|
50.18%
|
49.28%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/9/21
|
2/11/22
|
5/10/22
|
8/9/22
|
11/8/22
|
2/10/23
|
5/9/23
|
8/8/23
|
11/6/23
|
2/14/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
16.8%
|
27%
|
25.1%
|
11.4%
|
9.28%
|
13.9%
|
13.6%
|
13.3%
|
ROA (Net income/ Total Assets)
|
1.74%
|
2.25%
|
2.18%
|
-
|
-
|
1.37%
|
1.37%
|
1.47%
|
Assets
1 |
20,807
|
30,830
|
41,445
|
-
|
-
|
53,361
|
57,676
|
57,776
|
Book Value Per Share
2 |
101,085
|
131,368
|
165,837
|
-
|
-
|
205,539
|
231,668
|
261,684
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/11/22
|
2/10/23
|
2/14/24
|
-
|
-
|
-
|
Last Close Price
132,300
KRW Average target price
149,000
KRW Spread / Average Target +12.62% Consensus |